These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9706609)

  • 1. [Antiretroviral treatment with nucleoside analogs does not decrease the viremia of the hepatitis C virus in patients with HIV-1 infection].
    Macías J; Sánchez-Quijano A; Rey C; Lissen E
    Med Clin (Barc); 1998 Jun; 111(3):118-9. PubMed ID: 9706609
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
    Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
    J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy.
    Ragni MV; Bontempo FA
    J Infect Dis; 1999 Dec; 180(6):2027-9. PubMed ID: 10558963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
    Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
    Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.
    Cooper CL; Cameron DW
    Clin Infect Dis; 2002 Oct; 35(7):873-9. PubMed ID: 12228825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
    Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies.
    Pascual Pareja JF; Montes ML; González-García J; Arribas JR
    J Infect Dis; 2009 May; 199(10):1556-7; author reply 1557. PubMed ID: 19392631
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.
    De Rosa FG; Audagnotto S; Bargiacchi O; Garazzino S; Aguilar Marucco D; Veronese L; Canta F; Bonora S; Sinicco A; Di Perri G
    J Infect; 2006 Nov; 53(5):e215-8. PubMed ID: 16549201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection.
    Trimoulet P; Neau D; Le Bail B; Rullier A; Winnock M; Galperine T; Legrand E; Schvoerer E; Dupon M; Ragnaud JM; Bioulac-Sage P; Chêne G; Fleury H; Lafon ME
    J Med Virol; 2002 Jun; 67(2):143-51. PubMed ID: 11992575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
    Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
    J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
    Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
    J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV.
    Cooper CL; Cameron DW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S105-9. PubMed ID: 16265607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.